STAT3 and colorectal carcinoma: In colorectal cancer (CRC) cells, activated IL-6/STAT3 signals increased the expression of miR-181, which leaded to downregulating the expression of PDCD4 and promoting cell proliferation and metastasis and inhibit the apoptosis of CRC cells (46).